InsiderTrades.com logo
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
From Darwin   |   Ad
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
👉[Click here to get your FREE report delivered instantly!]

OLMA Insider Trading

Insider Ownership Percentage: 19.40%
Insider Buying (Last 12 Months): $3,031,235.30
Insider Selling (Last 12 Months): $38,275,642.48

Olema Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Olema Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Olema Pharmaceuticals Share Price & Price History

Current Price: $8.28
Price Change: ▼ Price Decrease of -0.44 (-5.05%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for OLMA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
From Colonial Metals   |   Ad
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…
>> YES! Send Me My FREE Gold Guide!

Olema Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/1/2024Biocapital Advisors L ParadigmMajor ShareholderSell2,400,000$14.91$35,784,000.00783,118View SEC Filing Icon  
7/29/2024Cyrus HarmonDirectorSell4,066$15.58$63,348.28752,217View SEC Filing Icon  
7/11/2024Cyrus HarmonDirectorSell5,000$12.26$61,300.00756,283View SEC Filing Icon  
6/28/2024Cyrus HarmonDirectorSell20,000$10.77$215,400.00761,283View SEC Filing Icon  
6/3/2024Cyrus HarmonDirectorSell5,000$10.93$54,650.00786,283View SEC Filing Icon  
5/31/2024Cyrus HarmonDirectorSell15,000$9.41$141,150.00791,283View SEC Filing Icon  
5/6/2024Cyrus HarmonDirectorSell5,000$10.92$54,600.00806,283View SEC Filing Icon  
4/30/2024Cyrus HarmonDirectorSell15,000$9.51$142,650.00811,283View SEC Filing Icon  
3/28/2024Cyrus HarmonDirectorSell20,000$10.97$219,400.00826,283View SEC Filing Icon  
2/29/2024Cyrus HarmonDirectorSell25,000$12.41$310,250.00846,283View SEC Filing Icon  
1/31/2024Cyrus HarmonDirectorSell25,000$12.23$305,750.00876,283View SEC Filing Icon  
12/6/2023Biocapital Advisors L ParadigmMajor ShareholderBuy100,000$11.60$1,160,000.006,590,981View SEC Filing Icon  
12/5/2023G. Walmsley GrahamDirectorBuy131,870$14.19$1,871,235.301,800,000View SEC Filing Icon  
11/30/2023Cyrus HarmonDirectorSell25,000$12.57$314,250.00926,283View SEC Filing Icon  
11/21/2023Cyrus HarmonDirectorSell4,192$14.86$62,293.12955,272View SEC Filing Icon  
11/21/2023Naseem ZojwallaInsiderSell7,461$14.84$110,721.2437,759View SEC Filing Icon  
11/21/2023Sean BohenCEOSell29,293$14.88$435,879.84172,857View SEC Filing Icon  
11/8/2023David C MylesInsiderSell200$17.61$3,522.00561,270View SEC Filing Icon  
11/3/2023David C MylesInsiderSell541$17.51$9,472.91561,470View SEC Filing Icon  
11/2/2023Cyrus HarmonDirectorSell5,000$15.64$78,200.00943,714View SEC Filing Icon  
11/1/2023David C MylesInsiderSell6,668$15.02$100,153.36565,343View SEC Filing Icon  
10/31/2023Cyrus HarmonDirectorSell25,000$12.05$301,250.00948,714View SEC Filing Icon  
9/29/2023Cyrus HarmonDirectorSell25,000$12.41$310,250.00973,714View SEC Filing Icon  
9/19/2023David C MylesInsiderSell20,000$12.67$253,400.00572,011View SEC Filing Icon  
9/12/2023Bvf Partners L P/IlDirectorBuy1,505,932$9.84$14,818,370.884,688,954View SEC Filing Icon  
9/5/2023Cyrus HarmonDirectorSell10,000$11.62$116,200.00998,714View SEC Filing Icon  
8/31/2023Cyrus HarmonDirectorSell15,000$9.36$140,400.001,008,714View SEC Filing Icon  
6/8/2023Cyrus HarmonDirectorSell10,000$6.30$63,000.001,038,714View SEC Filing Icon  
6/5/2023Cyrus HarmonDirectorSell5,000$6.04$30,200.001,053,714View SEC Filing Icon  
6/10/2022Bvf Partners L P/IlDirectorBuy200,000$4.03$806,000.003,913,676View SEC Filing Icon  
3/10/2022Kinney HornInsiderSell5,253$4.75$24,951.75View SEC Filing Icon  
1/10/2022Kinney HornInsiderSell5,251$6.85$35,969.35View SEC Filing Icon  
12/10/2021Kinney HornInsiderSell5,251$10.39$54,557.89View SEC Filing Icon  
11/30/2021Bvf Partners L P/IlDirectorBuy739,675$9.39$6,945,548.25View SEC Filing Icon  
11/29/2021Cyrus HarmonCTOSell400$24.76$9,904.00View SEC Filing Icon  
See Full Table
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
From Darwin   |   Ad
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
👉[Click here to get your FREE report delivered instantly!]

SEC Filings (Institutional Ownership Changes) for Olema Pharmaceuticals (NASDAQ:OLMA)

91.78% of Olema Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OLMA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Olema Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC94,915$1.13M0.0%+105.0%0.166%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC934,929$11.17M0.0%-11.8%1.632%Search for SEC Filing on Google Icon
11/15/2024Conway Capital Management Inc.10,000$0.12M0.1%N/A0.017%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC94,915$1.13M0.0%+105.0%0.166%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd25,332$0.30M0.0%+103.4%0.044%Search for SEC Filing on Google Icon
11/15/2024EP Wealth Advisors LLC48,655$0.58M0.0%+5.2%0.085%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP1,002,685$11.97M0.0%+10.8%1.750%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,969,963$23.52M0.0%+1.1%3.438%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.3,687,374$44.03M0.1%+14.8%6.435%Search for SEC Filing on Google Icon
11/15/2024Ikarian Capital LLC92,000$1.10M0.1%N/A0.161%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.74,919$0.90M0.0%-14.3%0.131%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC17,800$0.21M0.0%-68.2%0.031%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC212,185$2.53M0.9%-14.4%0.370%Search for SEC Filing on Google Icon
11/14/2024Portland Investment Counsel Inc.12,000$0.14M0.1%N/A0.021%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC75,974$0.91M0.0%-9.1%0.133%Search for SEC Filing on Google Icon
11/13/2024Great Point Partners LLC1,000,000$11.94M3.5%+25.5%1.746%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd19,894$0.24M0.0%N/A0.035%Search for SEC Filing on Google Icon
11/12/2024Pitcairn Co.24,546$0.29M0.0%-9.1%0.043%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.330,761$3.95M0.0%+168.5%0.578%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC13,686$0.16M0.0%N/A0.024%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.851,512$10.17M0.0%+9.9%1.487%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.11,014$0.13M0.0%+67.6%0.019%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.117,595$1.40M0.1%+34.7%0.205%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC13,056$0.16M0.0%N/A0.023%Search for SEC Filing on Google Icon
9/16/2024Cubist Systematic Strategies LLC13,416$0.15M0.0%N/A0.024%Search for SEC Filing on Google Icon
8/27/2024Dana Investment Advisors Inc.74,657$0.81M0.0%N/A0.133%Search for SEC Filing on Google Icon
8/15/2024Susquehanna Portfolio Strategies LLC26,549$0.29M0.0%-23.3%0.047%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company15,888$0.17M0.0%+52.2%0.028%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C31,405$0.34M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC275,000$2.98M0.3%N/A0.492%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC57,070$0.62M0.0%-22.4%0.102%Search for SEC Filing on Google Icon
8/14/2024Point72 Asset Management L.P.3,211,927$34.75M0.1%N/A5.742%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC13,416$0.15M0.0%N/A0.024%Search for SEC Filing on Google Icon
8/14/2024Great Point Partners LLC796,880$8.62M1.7%N/A1.425%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP588,996$6.37M0.0%+7.5%1.053%Search for SEC Filing on Google Icon
8/14/2024Logos Global Management LP3,208,875$34.72M2.8%-26.8%5.737%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC18,908$0.21M0.0%-58.2%0.034%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc14,849$0.16M0.0%+6.1%0.027%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd12,454$0.14M0.0%-53.8%0.022%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC53,200$0.58M0.0%N/A0.095%Search for SEC Filing on Google Icon
8/9/2024Dimensional Fund Advisors LP1,684,924$18.23M0.0%-13.0%3.012%Search for SEC Filing on Google Icon
8/8/2024American Century Companies Inc.11,832$0.13M0.0%-70.4%0.021%Search for SEC Filing on Google Icon
8/7/2024ClariVest Asset Management LLC63,149$0.68M0.1%+3.1%0.113%Search for SEC Filing on Google Icon
8/6/2024Candriam S.C.A.1,058,673$11.45M0.1%+199.9%1.893%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.774,792$8.38M0.0%+26.9%1.385%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers59,261$0.64M0.0%+43.5%0.106%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp139,923$1.51M0.0%+72.1%0.250%Search for SEC Filing on Google Icon
7/20/2024Hennion & Walsh Asset Management Inc.87,312$0.95M0.0%N/A0.156%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System34,695$0.39M0.0%+3.4%0.062%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.74,919$0.85M0.0%-49.9%0.134%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC1,221,662$13.82M0.0%+74.5%2.184%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD26,251$0.30M0.0%+6.0%0.047%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC14,530$0.16M0.1%+949.9%0.026%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC103,179$1.17M0.0%-59.7%0.184%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,407,688$27.26M0.0%-11.0%4.305%Search for SEC Filing on Google Icon
5/8/2024Entropy Technologies LP14,246$0.16M0.0%N/A0.025%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC15,565$0.18M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Portfolio Strategies LLC34,608$0.39M0.0%-4.9%0.062%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank70,300$0.80M0.0%+8.8%0.126%Search for SEC Filing on Google Icon
5/7/2024ClariVest Asset Management LLC61,268$0.69M0.1%-9.2%0.110%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.10,539$0.12M0.0%-33.9%0.019%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.10,562$0.12M0.0%+66.6%0.019%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC539,831$7.57M0.2%N/A0.980%Search for SEC Filing on Google Icon
2/14/2024First Light Asset Management LLC631,064$8.85M0.7%N/A1.145%Search for SEC Filing on Google Icon
2/14/2024Sectoral Asset Management Inc.19,230$0.27M0.1%-95.6%0.035%Search for SEC Filing on Google Icon
2/7/2024Dimensional Fund Advisors LP1,715,420$24.07M0.0%+1.3%3.113%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC19,866$0.28M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/6/2024Swiss National Bank64,600$0.91M0.0%N/A0.117%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.621,527$8.72M0.0%+879.6%1.128%Search for SEC Filing on Google Icon
1/30/2024Zurcher Kantonalbank Zurich Cantonalbank9,282$0.13M0.0%N/A0.017%Search for SEC Filing on Google Icon
1/24/2024Mirae Asset Global Investments Co. Ltd.15,951$0.22M0.0%+9.4%0.029%Search for SEC Filing on Google Icon
1/24/2024China Universal Asset Management Co. Ltd.6,341$89K0.0%N/A0.012%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC15,874$0.22M0.0%+38.1%0.029%Search for SEC Filing on Google Icon
12/19/2023Public Employees Retirement System of Ohio2,850$35K0.0%N/A0.005%Search for SEC Filing on Google Icon
12/18/2023Vanguard Group Inc.1,710,307$21.12M0.0%+2.2%3.123%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP99,121$1.22M0.0%+62.2%0.181%Search for SEC Filing on Google Icon
11/24/2023EP Wealth Advisors LLC46,248$0.57M0.0%+831.1%0.084%Search for SEC Filing on Google Icon
11/22/2023Polar Capital Holdings Plc750,000$9.26M0.1%N/A1.369%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP59,773$0.74M0.1%-41.3%0.145%Search for SEC Filing on Google Icon
11/15/2023Sectoral Asset Management Inc.437,652$5.41M1.1%-32.5%1.058%Search for SEC Filing on Google Icon
11/15/2023Kynam Capital Management LP235,176$2.90M0.5%-82.0%0.569%Search for SEC Filing on Google Icon
11/15/2023Acuta Capital Partners LLC153,007$1.89M1.3%+44.6%0.370%Search for SEC Filing on Google Icon
11/15/2023Adage Capital Partners GP L.L.C.388,982$4.80M0.0%+68.1%0.941%Search for SEC Filing on Google Icon
11/14/2023MPM Bioimpact LLC1,857,681$22.94M6.1%+301.7%4.493%Search for SEC Filing on Google Icon
11/14/2023Schonfeld Strategic Advisors LLC72,369$0.89M0.0%-42.4%0.175%Search for SEC Filing on Google Icon
11/14/2023Newtyn Management LLC150,000$1.85M0.5%-14.3%0.363%Search for SEC Filing on Google Icon
11/14/2023Caxton Associates LP13,474$0.17M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/13/2023Algert Global LLC47,630$0.59M0.0%-18.0%0.115%Search for SEC Filing on Google Icon
11/13/2023EAM Investors LLC243,290$3.01M0.6%+43.3%0.588%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC492,881$6.09M0.0%-14.9%1.192%Search for SEC Filing on Google Icon
11/13/2023ClariVest Asset Management LLC65,900$0.81M0.0%+23.9%0.159%Search for SEC Filing on Google Icon
11/13/2023Silverarc Capital Management LLC407,801$5.04M1.5%+4.4%0.986%Search for SEC Filing on Google Icon
11/8/2023Vivo Capital LLC1,873,704$23.14M2.9%+39.9%4.531%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund6,590$81K0.0%-45.5%0.016%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC4,657$57K0.0%-13.0%0.011%Search for SEC Filing on Google Icon
11/6/2023Victory Capital Management Inc.63,450$0.78M0.0%N/A0.153%Search for SEC Filing on Google Icon
10/24/2023Raymond James Financial Services Advisors Inc.13,287$0.16M0.0%N/A0.032%Search for SEC Filing on Google Icon
10/24/2023Raymond James & Associates30,000$0.37M0.0%N/A0.073%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC11,495$0.14M0.0%N/A0.028%Search for SEC Filing on Google Icon
10/11/2023Vontobel Holding Ltd.164,282$2.03M0.0%-28.3%0.397%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Olema Pharmaceuticals logo
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; and OP-1250 combine with CDK4/6 inhibitors palbociclib, ribociclib, and alpelisib in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer, as well as develops OPERA-01 for the of ER+/HER2- advanced or metastatic breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Read More on Olema Pharmaceuticals

Today's Range

Now: $8.28
Low: $8.12
High: $8.79

50 Day Range

MA: $11.77
Low: $8.28
High: $13.64

52 Week Range

Now: $8.28
Low: $8.12
High: $16.77

Volume

357,582 shs

Average Volume

733,452 shs

Market Capitalization

$474.43 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.02

Who are the company insiders with the largest holdings of Olema Pharmaceuticals?

Olema Pharmaceuticals' top insider investors include:
  1. Biocapital Advisors L Paradigm (Major Shareholder)
  2. Bvf Partners L P/Il (Director)
  3. G Walmsley Graham (Director)
  4. Cyrus Harmon (Director)
  5. David C Myles (Insider)
  6. Sean Bohen (CEO)
  7. Naseem Zojwalla (Insider)
Learn More about top insider investors at Olema Pharmaceuticals.

Who are the major institutional investors of Olema Pharmaceuticals?

Olema Pharmaceuticals' top institutional shareholders include:
  1. Point72 Asset Management L.P. — 6.44%
  2. State Street Corp — 3.44%
  3. Wellington Management Group LLP — 1.75%
  4. Great Point Partners LLC — 1.75%
  5. Geode Capital Management LLC — 1.63%
  6. Victory Capital Management Inc. — 1.49%
Learn More about top institutional investors of Olema Pharmaceuticals stock.

Which major investors are selling Olema Pharmaceuticals stock?

During the previous quarter, OLMA stock was sold by these institutional investors:
  1. Geode Capital Management LLC
  2. Janus Henderson Group PLC
  3. HighVista Strategies LLC
  4. Jacobs Levy Equity Management Inc.
  5. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  6. Pitcairn Co.
Within the last year, company insiders that have sold Olema Pharmaceuticals company stock include:
  1. Biocapital Advisors L Paradigm (Major Shareholder)
  2. Bvf Partners L P/Il (Director)
  3. G Walmsley Graham (Director)
  4. Cyrus Harmon (Director)
Learn More investors selling Olema Pharmaceuticals stock.

Which major investors are buying Olema Pharmaceuticals stock?

In the previous quarter, OLMA stock was acquired by institutional investors including:
  1. Point72 Asset Management L.P.
  2. Charles Schwab Investment Management Inc.
  3. Great Point Partners LLC
  4. Wellington Management Group LLP
  5. Ikarian Capital LLC
  6. Victory Capital Management Inc.
  7. Barclays PLC
  8. Barclays PLC
Within the previous year, these company insiders have bought Olema Pharmaceuticals stock:
  1. Biocapital Advisors L Paradigm (Major Shareholder)
  2. Bvf Partners L P/Il (Director)
  3. G Walmsley Graham (Director)
Learn More investors buying Olema Pharmaceuticals stock.
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share
From Darwin   |   Ad
The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.
👉[Click here to get your FREE report delivered instantly!]